Terms: = Lymphoma AND STAT6, D12S1644, 6778, ENSG00000166888, IL-4-STAT, P42226, STAT6B, STAT6C AND Clinical Outcome
4 results:
1. Activating stat6 mutations in follicular lymphoma.
Yildiz M; Li H; Bernard D; Amin NA; Ouillette P; Jones S; Saiya-Cork K; Parkin B; Jacobi K; Shedden K; Wang S; Chang AE; Kaminski MS; Malek SN
Blood; 2015 Jan; 125(4):668-79. PubMed ID: 25428220
[TBL] [Abstract] [Full Text] [Related]
2. Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma--a matched pair analysis from the German Hodgkin Study Group (GHSG).
Hartmann S; Eichenauer DA; Plütschow A; Mottok A; Bob R; Koch K; Bernd HW; Cogliatti S; Hummel M; Feller AC; Ott G; Möller P; Rosenwald A; Stein H; Hansmann ML; Engert A; Klapper W
Br J Haematol; 2014 Oct; 167(2):238-42. PubMed ID: 24965443
[TBL] [Abstract] [Full Text] [Related]
3. VEGF-A promotes lymphoma tumour growth by activation of STAT proteins and inhibition of p27(KIP1) via paracrine mechanisms.
Roorda BD; Ter Elst A; Scherpen FJ; Meeuwsen-de Boer TG; Kamps WA; de Bont ES
Eur J Cancer; 2010 Mar; 46(5):974-82. PubMed ID: 20064707
[TBL] [Abstract] [Full Text] [Related]
4. Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas.
Lu X; Nechushtan H; Ding F; Rosado MF; Singal R; Alizadeh AA; Lossos IS
Blood; 2005 Apr; 105(7):2924-32. PubMed ID: 15591113
[TBL] [Abstract] [Full Text] [Related]
